Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common GLP-1 fraud schemes

Jessica Johnson, clinical consultant at Prime Therapeutics, shares some ways to avoid common fraud schemes

Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common fraud schemes in health care.

Mitch Scott, senior director, Special Investigations Unit and pharmacy audit, shares how going beyond traditional FWA models helps enhance safety, and why that’s more important than ever

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to identify fraud

Jessica Johnson, clinical consultant at Prime, shares some tips to stay safe

Jessica Johnson, clinical consultant at Prime/Magellan Rx’s special investigations unit, shares how to help lower the risk of drug misuse.

Lassen, chief clinical officer at Prime Therapeutics/Magellan Rx, shares insights on GLP-1 weight-loss drugs and evidence-based approaches to providing the kind of care we’d want for our loved ones.